Treatment effects of the combination of ceftriaxone and valproic acid on neuronal and behavioural functions in a rat model of epilepsy

doi:10.1113/EP089624

CSMUIR > researcher portal > Artical > Item 310902500/23641

Please use this identifier to cite or link to this item: https://ir.csmu.edu.tw:8080/ir/handle/310902500/23641

Title:	Treatment effects of the combination of ceftriaxone and valproic acid on neuronal and behavioural functions in a rat model of epilepsy
Authors:	Li, HH;Lin, PJ;Wang, WH;Tseng, LH;Tung, H;Liu, WY;Lin, CL;Liu, CH;Liao, WC;Hung, CS;Ho, YJ
Keywords:	ceftriaxone;epilepsy;glutamate;seizure;valproic acid
Date:	2021
Issue Date:	2022-08-05T09:40:33Z (UTC)
Publisher:	WILEY
ISSN:	0958-0670
Abstract:	New Findings What is the central question of this study? Imbalance of activities between GABAergic and glutamatergic systems is involved in epilepsy. It is not known whether simultaneously increasing GABAergic and decreasing glutamatergic activity using valproic acid and ceftriaxone, respectively, leads to better seizure control. What is the central question of this study? Ceftriaxone suppressed seizure and cognitive deficits and restored neuronal density and the number of newborn cells in the hippocampus in a rat model of epilepsy. Combined treatment with ceftriaxone and valproic acid showed additive effects in seizure suppression. The pathophysiology of epilepsy is typically considered as an imbalance between inhibitory GABA and excitatory glutamate neurotransmission. Valproic acid (Val), a GABA agonist, is one of the first-line antiepileptic drugs in the treatment of epilepsy, but it exhibits adverse effects. Ceftriaxone (CEF) elevates expression of glutamate transporter-1, enhances the reuptake of synaptic glutamate, increases the number of newborn cells and exhibits neuroprotective effects in animal studies. In this study, we evaluated effects of the combination of CEF and Val on behavioural and neuronal measures in a rat epilepsy model. Male Wistar rats were injected i.p. with pentylenetetrazol (35 mg/kg, every other day for 13 days) to induce the epilepsy model. Ceftriaxone (10 or 50 mg/kg), Val (50 or 100 mg/kg) or the combination of CEF and Val were injected daily after the fourth pentylenetetrazol injection for seven consecutive days. Epileptic rats exhibited seizure and impairments in motor and cognitive functions. Treatment with CEF and Val reduced the seizure and enhanced motor and cognitive functions in a dose-dependent manner. The combination of CEF (10 mg/kg) and Val (50 mg/kg) improved behaviours considerably. Histologically, compared with control animals, epileptic rats exhibited lower neuronal density and a reduction in hippocampal newborn cells but higher apoptosis in the basolateral amygdala, all of which were restored by the treatment with CEF, Val or the combination of CEF and Val. The study findings demonstrated that the combination of low doses of CEF and Val has beneficial effects on seizure suppression, neuroprotection and improvement in motor and cognitive functions in epilepsy.
URI:	http://dx.doi.org/10.1113/EP089624 https://www.webofscience.com/wos/woscc/full-record/WOS:000666883900001 https://ir.csmu.edu.tw:8080/handle/310902500/23641
Relation:	EXPERIMENTAL PHYSIOLOGY ,2021,v106,issue 8, P1814-1828
Appears in Collections:	[researcher portal] Artical

Files in This Item:

File	Description	Size	Format
index.html		0Kb	HTML	206	View/Open

Loading...